ALL vs CNTA · P/E 4.9, $56.89B cap vs $6.15B cap
The Allstate Corporation (ALL) versus Centessa Pharmaceuticals PLC ADR (CNTA) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. CNTA currently screens at market cap $6.15B.
Not investment advice. Open the ALL and CNTA stock pages for the full models.
Not investment advice.